Kokubo Yasumasa
Kii ALS/PDC Research Center, Graduate School of Regional Innovation Studies, Mie University.
Brain Nerve. 2015 Jul;67(7):961-6. doi: 10.11477/mf.1416200238.
The diagnostic criteria for amyotrophic lateral sclerosis/parkinsonism-dementia complex in the Kii peninsula of Japan (Kii ALS/PDC) have been proposed. Muro disease has been considered an endemic neurodegenerative disease in the southern part of the Kii peninsula. Recent intensive and comprehensive research has revealed it to be a complex and genetically heterogeneous disease. At present, there are four subtypes of Muro disease: sporadic amyotrophic lateral sclerosis (ALS), Kii ALS/PDC with tauopathy, ALS with C9orf72 gene mutation, and ALS with optineurin gene mutation. The present criteria are applicable to only one of these subtypes, Kii ALS/PDC with tauopathy, which is quite similar to ALS/PDC in Guam.
日本纪伊半岛肌萎缩侧索硬化症/帕金森病-痴呆综合征(纪伊ALS/PDC)的诊断标准已被提出。室户病被认为是纪伊半岛南部的一种地方性神经退行性疾病。最近深入全面的研究表明它是一种复杂且基因异质性的疾病。目前,室户病有四种亚型:散发性肌萎缩侧索硬化症(ALS)、伴有tau蛋白病的纪伊ALS/PDC、伴有C9orf72基因突变的ALS以及伴有视紫质神经元基因(optineurin)突变的ALS。目前的标准仅适用于这些亚型中的一种,即伴有tau蛋白病的纪伊ALS/PDC,它与关岛的ALS/PDC非常相似。